Ann Clin Surg | Volume 4, Issue 1 | Case Report | Open Access

The First Case of Left Ventricular Assist Device Implantation (Artificial Heart) in Ningxia

Li M¹, Jin L², Lu Z², Bai X¹, Jiang B¹, Song Y¹, Chen L³, Dai X³ and Wang Y^1*

¹General Hospital of Ningxia Medical University, China ²Ningxia Medical University, China ³Union Hospital Affiliated to Fujian Medical University, China

^*Correspondance to: Wang Yun 

Fulltext PDF

Abstract

On October 01st, 2022, our hospital successfully implanted a left ventricular assist device (artificial heart) in a patient with dilated cardiomyopathy. The patient recovered well after the operation and was discharged successfully on the 9th day after the operation. After discharge, the patient received lifelong anticoagulant treatment with aspirin and warfarin, reviewed the blood coagulation function regularly, adjusted the amount of warfarin according to the blood coagulation situation, so that the INR was always maintained between 2.0 and 3.0, and came to our hospital's outpatient clinic for review regularly. The operation of the left ventricular assist device (artificial heart) was evaluated, and the medication was adjusted according to the condition.

Keywords:

Left ventricular assist device; Artificial heart Dilated cardiomyopathy

Citation:

Li M, Jin L, Lu Z, Bai X, Jiang B, Song Y, et al. The First Case of Left Ventricular Assist Device Implantation (Artificial Heart) in Ningxia. Ann Clin Surg. 2023; 4(1): 1027.